Back
Vistagen Therapeutics Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
VTGN
Vistagen Therapeutics
Last Price:
$2.22
Seasonality Move:
-9.49%
7 Day Trial
ALL ACCESS PASS
$
7
Vistagen Therapeutics Stock Forecast
-
Is Vistagen Therapeutics Stock Undervalued?The current Vistagen Therapeutics [VTGN] share price is $2.22. The Score for VTGN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
VTGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Vistagen Therapeutics Stock Go Up Next Year?
Data Unavailable
Vistagen Therapeutics Stock Rating
Data Unavailable
Vistagen Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vistagen.com
52-Week Data
52-Week High:
4.96
52-Week Low:
1.90
Prediction Charts
Market Cap:
64.1M
Price in USD:
2.22
Volume:
73.6K
Beta:
-0.40
Technical Analysis
SMA50:
2.53
SMA100:
2.66
SMA200:
2.94
52-Wk Change:
-52.77%
Stock Predictions
-
Is Vistagen Therapeutics stock public?Yes, Vistagen Therapeutics is a publicly traded company.
-
What is the Vistagen Therapeutics stock quote today?The Vistagen Therapeutics stock price is 2.22 USD today.
-
How to buy Vistagen Therapeutics stock online?You can buy Vistagen Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-7 | 2.22 | 2.17 | 2.30 | 2.09 |
Apr-8 | 2.24 | 2.03 | 2.24 | 2.03 |
Apr-9 | 2.00 | 2.06 | 2.16 | 1.90 |
Apr-10 | 2.08 | 2.05 | 2.20 | 1.96 |
Apr-11 | 2.06 | 2.12 | 2.12 | 2.01 |
Apr-14 | 2.14 | 2.23 | 2.25 | 2.13 |
Apr-15 | 2.24 | 2.22 | 2.32 | 2.22 |
Apr-16 | 2.24 | 2.07 | 2.24 | 1.97 |
Apr-17 | 2.07 | 2.11 | 2.13 | 2.00 |
Apr-21 | 2.10 | 2.10 | 2.14 | 2.01 |
Apr-22 | 2.12 | 2.05 | 2.12 | 2.00 |
Apr-23 | 2.09 | 2.18 | 2.20 | 2.08 |
Apr-24 | 2.18 | 2.34 | 2.34 | 2.17 |
Apr-25 | 2.31 | 2.22 | 2.34 | 2.22 |
Vistagen Therapeutics Earnings
Data Unavailable
Vistagen Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.40 per share.
* Vistagen Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.